← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2017-03-21

Drug application

FDA Application #

ANDA207474

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

OXALIPLATIN

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACCORD HLTHCARE

Manufacturer

Accord Healthcare Inc.

First approval

2017-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown